Korean Stock
EXCH
Daewoong
★★★★
Completion of Succession of Licensor Position for mRNA ERA Technology... Securing Right to Receive Up to $239M
 19h ago
PERI
Daewoong
★
Daewoong 1Q26 Consolidated Sales KRW 492.7B, OP KRW 47.8B – Routine Quarterly Results
 05/15/2026, 03:41 PM
EXCH
Daewoong
★★
Daewoong Pharmaceutical Signs Technology Introduction Agreement for 15-PGDH Inhibitor INV-008 (Up to KRW 662.5 Billion)
 05/12/2026, 05:42 PM
EXCH
Daewoong
★★
Daewoong Pharmaceutical Acquires Licensor Status for mRNA-based ERA Platform
 05/07/2026, 05:04 PM
EXCH
Daewoong
★★★
Daewoong Pharma Gets Nod for Fexuclue H. pylori Eradication Indication
 05/03/2026, 07:00 AM